The sixth Risperdal case to go to trial in the Philadelphia mass tort program against manufacturers Janssen Pharmaceuticals and Johnson & Johnson (J&J) has come to an abrupt end...
Just weeks after healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals reached a confidential settlement with a Risperdal plaintiff, the companies are going to trial in...
Since healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals settled a Risperdal case in October, other plaintiffs in the Risperdal litigation hoped the settlement would set...
Healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals were likely shocked by the $70 million plaintiff’s verdict after the fifth Risperdal trial this past July. The...
For thousands of Risperdal lawsuits pending in Philadelphia, a judges ruling could see their cases dismissed. A Pennsylvania appeals court has heard arguments from both sides regarding when the...